Companies
/
Brightseed
Healthtech
Brightseed is a biotechnology company that uses AI to discover bioactive plant compounds and their health benefits, aiming to develop them into ingredients for food, supplement, and pharmaceutical products.
Create an account to view live offerings, pricing, and market activity.
Sign in to view offerings and live market activity.
Brightseed was founded in 2017 by Jim Flatt and Sonia Iyer, based on the observation that plants contain an enormous, largely uncharacterized universe of bioactive chemical compounds, sometimes called phytochemicals, many of which likely have meaningful effects on human health but have never been systematically identified, characterized, or connected to specific biological mechanisms, in part because traditional methods of natural compound discovery are slow, labor-intensive, and have historically focused on only a small, well-studied subset of known plant chemistry. The company built an AI platform, called Forager, that analyzes plant chemical composition data alongside biological and health outcome data to identify candidate bioactive compounds and predict their likely biological mechanisms and health effects far more quickly than traditional laboratory-based discovery methods would allow. Brightseed has applied this discovery platform to identify specific compounds with potential applications across areas such as metabolic health, gut health, and healthy aging, then works to validate these compounds through further laboratory and clinical research before developing them into ingredients that can be licensed to food, beverage, dietary supplement, and pharmaceutical companies for use in their own products. One of the company's most prominent discoveries, a compound called dihydroberberine derived from Indian barberry root, has been developed into a commercial ingredient marketed for metabolic health applications, illustrating the company's model of using AI-driven discovery to identify a promising natural compound and then partnering with other companies to bring it to market in consumer or pharmaceutical products rather than manufacturing and marketing end products itself. Brightseed has positioned its approach as significantly accelerating a category of natural product discovery that has historically moved very slowly, and has raised substantial venture funding from investors including Danone Manifesto Ventures and Viking Global Investors, reflecting interest from both strategic food and beverage companies and financial investors in AI-accelerated natural ingredient discovery.
Sources:
FOR QUALIFIED INSTITUTIONAL AND ACCREDITED INVESTORS ONLY: Under federal securities laws, private market investments on this platform are available exclusively to Institutional and Accredited Investors. Verification of status required before investing. Private investments involve significant risks including illiquidity, potential loss of principal, and limited disclosure requirements. "Augment" refers to Augment Markets, Inc. and its affiliates. Augment Markets, Inc. is a technology company offering software and data services, not a bank or financial institution. Cash Accounts are provided by Modern Treasury Corp. financial institution partners and through Augment's technology. Augment does not act as a money services business, provide money transmission, or serve as a custodian of funds. Funds held in your Cash Account are not FDIC insured unless expressly disclosed. Full terms available in the Augment Cash Account Agreement. Brokerage services are offered through Augment Capital, LLC, an affiliated broker-dealer and member FINRA/SIPC. "Investment accounts" are not brokerage accounts and do not hold customer funds or securities. Investment advisory services are offered through Augment Advisors, LLC, an SEC-registered investment adviser. Registration with the SEC does not imply a certain level of skill or training. Neither Augment Advisors, LLC nor Augment Capital, LLC provide legal or tax advice; consult your attorney or tax professional regarding your specific situation. For additional information, please refer to Augment Advisors, LLC's Form ADV Part 2A (Firm Brochure) and FINRA BrokerCheck.
No news available for this company.
